Kinins, receptors, kininases and inhibitors - Where did they lead us?

Biological Chemistry

Volumn 382, Issue 1, 2001, Pages 43-48

  Erdos E G ^a   Marcic, B M ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

ACE; B2 receptor; Bradykinin potentiation; PKC; Receptor resensitization

Indexed keywords

BRADYKININ DERIVATIVE; BRADYKININ RECEPTOR; DIMER; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENZYME INHIBITOR; KININ; KININASE; OKADAIC ACID; PEPTIDE; PHOSPHATASE; PROTEIN KINASE C INHIBITOR; RAMIPRILAT;

ALLOSTERISM; ANIMAL CELL; CHEMICAL MODIFICATION; CHO CELL; CONTROLLED STUDY; DESENSITIZATION; ENZYME ACTIVE SITE; EXPERIMENT; GENETIC TRANSFECTION; GUINEA PIG; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PUBLICATION; RECEPTOR SENSITIVITY; REVIEW; SENSITIZATION; SIGNAL TRANSDUCTION; TISSUE PREPARATION;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BRADYKININ; HUMANS; KININS; LYSINE CARBOXYPEPTIDASE; PEPTIDYL-DIPEPTIDASE A; RECEPTORS, CELL SURFACE;

ANIMALIA; CAVIA PORCELLUS; SUS SCROFA;

EID: 0035113011     PISSN: 14316730     EISSN: None     Source Type: Journal    
DOI: 10.1515/BC.2001.007     Document Type: Review

References (35)

1. Sensitization of guinea pig ileum to the action of bradykinin by trypsin hydrolysate of ox and rabbit plasma
2. Local regulation of vascular tone by bradykinin and angiotensin converting enzyme inhibitors
3. ACE inhibitors are endothelium dependent vasodilators of coronary arteries during submaximal stimulation with bradykinin
4. Angiotensin-converting enzyme inhibitor ramiprilat interferes with the sequestration of the B2 kinin receptor within the plasma membrane of native endothelial cells
5. Bioregulation of kinins: Kallikreins, kininogens, and kininases
6. Ligand-induced phosphorylation/dephosphorylation of the endogenous bradykinin B2 receptor from human fibroblasts
7. Structure-function studies on the bradykinin potentiating peptide from Chinese snake venom (Agkistrodon halys Pallas)
8. 2 receptor selective agonist which is not broken down by either kininase I or kininase II
9. Kininases
10. Kininases
11. Potentiation of bradykinin actions by ACE inhibitors
12. Angiotensin converting enzyme inhibition in patients with congestive heart failure
13. Potentiation by ACE inhibitors of the dilator response to bradykinin in the coronary microcirculation: Interaction at the receptor level
14. ACE inhibitors potentiation of bradykinin-induced venoconstriction
15. Amino acid sequence of bradykinin-potentiating peptide isolated from the venom of Agkistrodon halys blomhoffii
16. Structure of bradykinin-potentiating peptide containing tryptophan from the venom of Agkistrodon halys blomhoffii
17. Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors
18. Protein kinase C and phosphatase inhibitors block the ability of ACE inhibitors to resensitize the receptor to bradykinin, without altering the primary effects of bradykinin
19. 2 receptor
20. Effects of the N-terminal sequence in the N-domain of ACE on the properties of its C-domain
21. 2 bradykinin receptor by ACE inhibitors
22. Potentiation of the actions of bradykinin by angiotensin I converting enzyme (ACE) inhibitors. The role of expressed human bradykinin B2 receptors and ACE in CHO cells
23. Potentiation of the effects of bradykinin on its receptor in the isolated guinea pig ileum
24. Studies on the physiological activity of peptides released during the fibrinogen-fibrin conversion
25. Negative cooperativity in the human bradykinin B2 receptor
26. Bradykinin receptors undergo ligand-induced desensitization
27. SQ14,225 (D-3-mercapto-2-methylpropanoyl-L-proline), a novel orally active inhibitor of angiotensin I-converting enzyme
28. Bradykinin potentiating peptide PCA-Lys-Trp-Ala-Pro- an inhibitor of the pulmonary inactivation of bradykinin and conversion of angiotensin I to II
29. Studies on the mechanism of bradykinin potentiation
30. The mechanism of action of two bradykinin-potentiating peptides on isolated smooth muscle
31. Neure Aspekte der Kininforschung. I. Potenzierung und Blockierung der biologischen Kininwirkung
32. Über die Wirkung des Kallikreins auf den isolierten Darm und über eine neue darmkontrahierende Substanz
33. A dipeptidyl carboxypeptidase that converts angiotensin I and inactivates bradykinin
34. Characterization of a dipeptide hydrolase (kininase II; angiotensin I converting enzyme)
35. Effects of an angiotensin-converting enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients